Model species |
Mouse |
Mouse |
Mouse |
Mouse |
Mouse |
Mouse |
Macaque |
Induction of disease model (in Adults) |
Epsilon toxin, produced by type B and D strains of Clostridium perfringens, a spore-forming gram-positive bacterium |
Timed genetic expression of diphtheria toxin (tamoxifen induced PLPCreERT for targeting OL) |
Cuprizone diet for 2 weeks, then inject CFA (SubQ) and Pertussis Toxin (IP) |
MOG35–55 + CFA (SubQ) and Pertussis Toxin (IP) |
PLP139–151 + CFA (SubQ) |
Theiler’s Murine Encephalomyelitis Virus (TMEV) intracerebral infection |
Japanese Macaque Rhadinovirus (JMRV), spontaneous or injected |
Disease model trigger |
Epsilon Toxin induced cytotoxicity (OL) |
DTA induced cell death (OL), secondary MOG peptide immune response |
Cuprizone destabilizes myelin, Citrullinated MBP drives immune response |
MOG35–55 peptide immune response |
PLP139–151 peptide immune response |
Response to TMEV and subsequent spreading to PLP and MBP epitopes |
JMRV infection, MBP peptide immune response |
Disease model pathogenesis |
OL cytotoxicity, triggers demyelination |
OL ablation, triggers demyelination/remyelination, secondary immune response (respond to MOG peptide) |
Myelin breakdown, secondary immune response (respond to MBP epitope) |
Immune infiltration (respond to MOG peptide), secondary CNS degeneration |
Immune infiltration (initially respond to PLP peptide, later to MBP), secondary CNS degeneration |
Immune response to virus, release of myelin epitopes inducing autoimmune pathology, secondary CNS degeneration |
Immune response to virus and infiltration (respond to MBP peptide), secondary CNS degeneration |